Arcadia Biosciences, Inc.

RKDA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,242$6,518$20,644$28,685
Short-Term Investments$0$5,124$0$0
Receivables$1,175$514$1,221$1,370
Inventory$904$1,958$2,321$4,433
Other Curr. Assets$2,921$858$1,212$900
Total Curr. Assets$9,242$14,972$25,398$35,388
Property Plant & Equip (Net)$178$1,176$2,528$5,372
Goodwill$0$0$0$0
Intangibles$39$39$40$484
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,058$3,518$956$2,674
Total NC Assets$4,275$4,733$3,524$8,530
Other Assets$0$0$0$0
Total Assets$13,517$19,705$28,922$43,918
Liabilities
Payables$703$801$905$1,411
Short-Term Debt$155$852$1,010$1,074
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,705$1,937$2,294$2,555
Total Curr. Liab.$2,563$3,590$4,209$5,040
LT Debt$0$155$1,007$2,220
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,731$3,257$2,806$5,462
Total NC Liab.$4,731$3,412$3,813$7,682
Other Liabilities$0$0$0$0
Cap. Leases$155$1,007$2,017$3,294
Total Liabilities$7,294$7,002$8,022$12,722
Equity
Pref Stock$0$0$0$0
Common Stock$65$65$65$63
Retained Earnings-$278,878-$271,840-$257,859-$226,485
AOCI$0$101$0$0
Other Equity$285,036$284,515$278,827$257,515
Total Equity$6,223$12,841$21,033$31,093
Supplemental Information
Minority Interest$0-$138-$133$103
Total Liab. & Tot. Equity$13,517$19,705$28,922$43,918
Net Debt-$4,087-$5,511-$18,627-$25,391